Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVS SR (25 and 50 mg) in Adult Outpatients With Major Depressive Disorder
NCT00798707Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started Dec 2008; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00798707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798707.